News
Revolutionary EMS & Copper Technology Offers Clinically-Tested Relief for Neuropathy, Tingling, and Chronic Foot Pain-Now ...
GUILDFORD, UNITED KINGDOM / ACCESS Newswire / June 6, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in ...
The digital pharmaceutical supply chain management market is projected to grow at a CAGR of 9% from 2025 to 2030. The growth ...
The MRI systems market is projected to grow at a CAGR of ~5% over the forecast period. Major factors driving the growth ...
The negative pressure wound therapy market is projected to grow at a CAGR of ~6% over the forecast period. Major factors ...
The global cell sorting market is set to witness a growth rate of 8% in the next 5 years. increasing research in life ...
The Klinefelter syndrome (KS) therapeutics market is projected to grow at a CAGR of 6–8% during the forecast period driven by ...
The global contrast media APIs market is set to witness a growth rate of 5% in the next 5 years. Rising volume of diagnostic ...
The global premenstrual syndrome treatment market is expected to grow at a CAGR of around 5% during the forecast period. This ...
The global peripheral vascular devices market is set to witness a growth rate of 6% in the next 5 years. Rising prevalence of ...
The global photodynamic therapy (PDT) devices market is set to witness a growth rate of 9% in the next 5 years. Rising ...
MILWAUKEE, WISCONSIN / ACCESS Newswire / June 5, 2025 / Serve You Rx announced today that its Biosimilar Advantage Formulary now includes two newly approved biosimilars to Stelara® (ustekinumab): ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results